Patent details

EP2650378 Title: Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

Basic Information

Publication number:
EP2650378
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP131671745
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
French Title of Invention:
Utilisation d'essais génomiques et composés cétogéniques pour le traitement d'une fonction cognitive réduite
German Title of Invention:
Verwendung genomischer und ketogener Verbindungen zur Behandlung von beeinträchtigten kognitiven Funktionen
SPC Number:

Dates

Filing date:
31/07/2008
Grant date:
16/09/2015
EP Publication Date:
16/09/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/10/2013
EP B1 Publication Date:
16/09/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
31/07/2016
Expiration date:
31/07/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2008
 
 

Name:
Accera Inc.
Address:
380 Interlocken Crescent, Suite 780, Broomfield, Colorado 80021, United States (US)

Inventor

Name:
Henderson Samuel T.
Address:
United States (US)

Priority

Priority Number:
953074 P
Priority Date:
31/07/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C12Q 1/68;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages